Diagnosis, IT, Specialization and Webinar

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

FDA Law

FEBRUARY 27, 2023

While no “special registration” will yet be required to engage in telemedicine prescribing of controlled substances, DEA is proposing parameters to guide the practice of telemedicine encounters in a post-COVID world. We will release exciting details of our upcoming webinar addressing telemedicine soon. 21 U.S.C. § 802(54)(D)(i).

Telemedicine

Telemedicine Telecommunication Telehealth Medical

Hospital-at-Home: Bruce Leff and Tacara Soones

GeriPal

SEPTEMBER 14, 2023

In addition to discussing these outcomes, we also discuss: The history of the hospital-at-home movement. The practicalities of how it works including who are good candidates, where does it start (the ED?), what happens at home, do you need a caregiver, what happens if they need something like imaging? How is it financed and what comes next?

Hospital

Hospital Patient-Centered Supply Chain IT

Primary Care Digest

Telemedicine and the Prescribing of Controlled Substances After the End of The Covid-19 Pandemic Emergency: DEA Announces Two Significant Proposed Rules: Read the Summary Below, But Learn All the Details and More at HPM’s Webinar on March 23, 2023 (Details Forthcoming….)

Hospital-at-Home: Bruce Leff and Tacara Soones

Stay Connected